Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LORAZEPAM Cause Contraindicated product administered? 125 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Contraindicated product administered have been filed in association with LORAZEPAM (Lorazepam). This represents 0.4% of all adverse event reports for LORAZEPAM.

125
Reports of Contraindicated product administered with LORAZEPAM
0.4%
of all LORAZEPAM reports
49
Deaths
96
Hospitalizations

How Dangerous Is Contraindicated product administered From LORAZEPAM?

Of the 125 reports, 49 (39.2%) resulted in death, 96 (76.8%) required hospitalization, and 60 (48.0%) were considered life-threatening.

Is Contraindicated product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 125 reports have been filed with the FAERS database.

What Other Side Effects Does LORAZEPAM Cause?

Drug ineffective (3,775) Drug abuse (3,741) Toxicity to various agents (2,836) Completed suicide (2,340) Off label use (2,178) Somnolence (2,114) Sopor (2,042) Anxiety (1,573) Fall (1,524) Overdose (1,516)

What Other Drugs Cause Contraindicated product administered?

ABATACEPT (13,559) METHOTREXATE (13,121) ETANERCEPT (12,062) TOCILIZUMAB (11,547) ADALIMUMAB (11,270) LEFLUNOMIDE (11,206) HYDROXYCHLOROQUINE (10,557) RITUXIMAB (10,479) INFLIXIMAB (9,618) SULFASALAZINE (8,698)

Which LORAZEPAM Alternatives Have Lower Contraindicated product administered Risk?

LORAZEPAM vs LORCASERIN LORAZEPAM vs LORLATINIB LORAZEPAM vs LORMETAZEPAM LORAZEPAM vs LORNOXICAM LORAZEPAM vs LOSARTAN

Related Pages

LORAZEPAM Full Profile All Contraindicated product administered Reports All Drugs Causing Contraindicated product administered LORAZEPAM Demographics